Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | RECQL | P46063 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | STAT6 | P42226 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | MITF | O75030 | 1/20 | 0.36 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29241858 | 0.95 | SMN1; SMN2 (0.36) | MAPTSMN1; SMN2RECQLKDM4EMEN1 | |
| SCHEMBL1395635 | 0.87 | SMN1; SMN2 (0.35) | MAPTSMN1; SMN2RECQLMEN1KMT2A | |
| SCHEMBL16436870 | 0.86 | SMN1; SMN2 (0.36) | MAPTSMN1; SMN2RECQLKDM4EMEN1 | |
| SCHEMBL5019491 | 0.83 | LMNA (0.44) | MAPTSMN1; SMN2RECQLKDM4EMEN1 | |
| SCHEMBL18012879 | 0.83 | LMNA (0.44) | MAPTSMN1; SMN2RECQLKDM4EMEN1 | |
| SCHEMBL1374699 | 0.83 | LMNA (0.44) | MAPTSMN1; SMN2RECQLKDM4EMEN1 | |
| SCHEMBL26710849 | 0.83 | LMNA (0.37) | MAPTSMN1; SMN2RECQLMEN1KMT2A | |
| SCHEMBL11816203 | 0.82 | HTT (0.44) | SMN1; SMN2MEN1CYP1A2KMT2AALDH1A1 | |
| SCHEMBL14003612 | 0.81 | SMN1; SMN2 (0.32) | SMN1; SMN2MEN1KMT2ALMNAMITF | |
| SCHEMBL16151989 | 0.81 | KDM4E (0.43) | KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240393345-A1 | Protein Capture Membrane and Method of Use Thereof | UNIV YALE (US) | 2024-11-28 | — | — | US | claimed |
| US-11975091-B2 | Composition for enhancing protein strength | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2024-05-07 | — | — | US | claimed |
| CN-110191701-B | Composition for enhancing protein strength | 株式会社LG生活健康 | 2023-02-21 | — | — | CN | claimed |
| US-20210401714-A1 | Composition For Enhancing Protein Strength | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2021-12-30 | — | — | US | claimed |
| US-20210132077-A1 | Protein Capture Membrane and Method of Use Thereof | CONNECTICUT INNOVATIONS, INCORPORATED | 2021-05-06 | — | — | US | claimed |
| CN-112292594-A | Protein capture membranes and methods of use thereof | 耶鲁大学 | 2021-01-29 | — | — | CN | claimed |
| CN-111978481-A | Alkali-free water reducing agent and preparation method thereof | 东莞创利科技发展有限公司 | 2020-11-24 | — | — | CN | claimed |
| US-20200138688-A1 | Composition For Enhancing Protein Strength | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2020-05-07 | — | — | US | claimed |
| US-20260027542-A1 | BIOLOGICAL SAMPLE CAPTURE WITH MULTIPLEX ANALYSIS | PROTEOWISE INC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12447456-B2 | Biological sample capture with multiplex analysis | PROTEOWISE INC. (US) | 2025-10-21 | — | — | US | disclosed |
| US-20250319238-A1 | COATING COMPOSITION FOR MEDICAL IMPLANTS TO PREVENT FOREIGN SUBSTANCE ADHESION | LYNK SOLUTEC INC. (KR) | 2025-10-16 | — | — | US | disclosed |
| US-20250288731-A1 | COATING COMPOSITION FOR PROTECTION OF ENDOSCOPE | LYNK SOLUTEC INC (KR) | 2025-09-18 | — | — | US | disclosed |
| EP-4555030-A1 | PROTECTION COATING COMPOSITION, TREATING METHOD USING THE SAME AND ARTICLE THEREOF | Henkel AG & Co. KGaA (DE) | 2025-05-21 | — | — | EP | disclosed |
| EP-4555023-A1 | CORROSION PROTECTION PRETREATMENT AGENT, TREATING METHOD USING THE SAME AND ARTICLE THEREOF | Henkel AG & Co. KGaA (DE) | 2025-05-21 | — | — | EP | disclosed |
| US-20080317943-A1 | METHOD FOR FORMING PATTERN, METHOD FOR MANUFACTURING ELECTRO-OPTICAL DEVICE, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE | SEIKO EPSON CORPORATION (JP) | 2008-12-25 | — | — | US | disclosed |
| US-20080311285-A1 | CONTACT HOLE FORMING METHOD, CONDUCTING POST FORMING METHOD, WIRING PATTERN FORMING METHOD, MULTILAYERED WIRING SUBSTRATE PRODUCING METHOD, ELECTRO-OPTICAL DEVICE PRODUCING METHOD, AND ELECTRONIC APPARATUS PRODUCING METHOD | SEIKO EPSON CORPORATION (JP) | 2008-12-18 | — | — | US | disclosed |
| US-20060240198-A1 | Curing resin composition, sealing material for liquid crystal display device and liquid crystal display device | SEKISUI CHEMICAL CO., LTD. | 2006-10-26 | — | — | US | disclosed |
| US-20060127563-A1 | Patterned substrate, electro-optical device, and method for manufacturing an electro-optical device | SEIKO EPSON CORPORATION (JP) | 2006-06-15 | — | — | US | disclosed |
| US-20060019034-A1 | Process for producing chemical adsorption film and chemical adsorption film | SEIKO EPSON CORPORATION (JP) | 2006-01-26 | — | — | US | disclosed |
| US-20050287392-A1 | Organic electroluminescent device, method for producing the same, and electronic apparatus | SEIKO EPSON CORPORATION (JP) | 2005-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210401714-A1 | Composition For Enhancing Protein Strength | CUTA, S100A4, S100A8 | MAPT 1134/4885SMN1; SMN2 3803/4885RECQL 4828/4885 |
| US-20260027542-A1 | BIOLOGICAL SAMPLE CAPTURE WITH MULTIPLEX ANALYSIS | ALPP, TMPRSS2, CD63 | MAPT 2294/4885SMN1; SMN2 2673/4885RECQL 2080/4885 |
| US-11975091-B2 | Composition for enhancing protein strength | CUTA, S100A4, S100A8 | MAPT 1134/4885SMN1; SMN2 3803/4885RECQL 4828/4885 |
| US-20200138688-A1 | Composition For Enhancing Protein Strength | CUTA, S100A4, S100A8 | MAPT 1134/4885SMN1; SMN2 3803/4885RECQL 4828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.